EIC Accelerator - 2 life sciences start-ups from Berlin among the 71 selected companies

In the most competitive financing round to date, the European Innovation Council (EIC) selected a total of 71 companies from 1,211 applications.

Two Berlin start-ups were able to impress with their business model:

Noah Labs receives 11 million euros in funding, and wants to revolutionize heart failure detection using AI-based voice monitoring.

MyoPax, a spin-off from the Max Delbrück Centrum and Charité - Universitätsmedizin Berlin, is developing a generative gene therapy for muscular dystrophies, which affect over 20 million EU citizens and for which there are no adequate treatment options in most cases.

Further information:

Back